Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Whether youre just beginning or have tried other methods without success, were here to provide you with the tools you need to succeed
These are trademarked products not affiliated with our platform
The platform collects payment and organizes access before any individualized medical determination is made
Key Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of either 10 mg or 15 mg once weekly, has demonstrated superiority to semaglutide in this indication
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
